Review



recombinant human md 2 rhmd 2 protein  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems recombinant human md 2 rhmd 2 protein
    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding <t>to</t> <t>MD2</t> promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Recombinant Human Md 2 Rhmd 2 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+md+2+rhmd+2+protein/Recombinant+Human+MD-2+Protein/pm30091835-33-0-8
    Average 94 stars, based on 28 article reviews
    recombinant human md 2 rhmd 2 protein - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "25-Hydroxycholesterol protects against acute lung injury via targeting MD-2."

    Article Title: 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.

    Journal: Journal of cellular and molecular medicine

    doi: 10.1111/jcmm.13820

    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding to MD2 promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Figure Legend Snippet: FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding to MD2 promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway

    Techniques Used: Binding Assay, Activation Assay, Phospho-proteomics, Gene Expression

    Related Articles

    other:

    Article Title: Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Article Snippet: Anti-CD68, anti-MD-2 and anti-TLR4 antibodies were purchased from Santa Cruz (Santa Cruz, CA, USA).

    Article Title: 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.
    Article Snippet: 25HC, LPS (E. coli O111:B4) and fluorescein isothiocyanate‐labelled LPS (FITC‐LPS) were purchased from Sigma‐Aldrich (St. Louis, MO, USA).

    Recombinant:

    Article Title: 25‐Hydroxycholesterol protects against acute lung injury via targeting MD ‐2
    Article Snippet: 25HC, LPS ( E. coli O111:B4) and fluorescein isothiocyanate‐labelled LPS (FITC‐LPS) were purchased from Sigma‐Aldrich (St. Louis, MO, USA). .. Recombinant human MD‐2 (rhMD‐2) protein was obtained from R&D Systems (Minneapolis, MN, USA). .. Biotin‐LPS was purchased from Invivogen (San Diego, CA, USA).

    Article Title: Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS ‐induced acute lung injury
    Article Snippet: Anti‐CD68, anti‐MD‐2 and anti‐TLR4 antibodies were purchased from Santa Cruz (Santa Cruz, CA, USA). .. Recombinant human MD‐2 (rhMD‐2) protein was purchased from R&D Systems, Inc. (Minneapolis, MN, USA). ..



    Similar Products

    recombinant human md 2 rhmd 2 protein  (R&D Systems)
    94
    R&D Systems recombinant human md 2 rhmd 2 protein
    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding <t>to</t> <t>MD2</t> promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Recombinant Human Md 2 Rhmd 2 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+md+2+rhmd+2+protein/Recombinant+Human+MD-2+Protein/pm30091835-33-0-8
    Average 94 stars, based on 1 article reviews
    recombinant human md 2 rhmd 2 protein - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    rhmd 2  (R&D Systems)
    94
    R&D Systems rhmd 2
    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding <t>to</t> <t>MD2</t> promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Rhmd 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+md+2+rhmd+2+protein/Recombinant+Human+MD-2+Protein/pm28296959-73-25-27
    Average 94 stars, based on 1 article reviews
    rhmd 2 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    recombinant human md-2 (rhmd-2, or rhmd-2 mutant) proteins  (Biowit Technologies)
    90
    Biowit Technologies recombinant human md-2 (rhmd-2, or rhmd-2 mutant) proteins
    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding <t>to</t> <t>MD2</t> promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Recombinant Human Md 2 (Rhmd 2, Or Rhmd 2 Mutant) Proteins, supplied by Biowit Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+md+2+rhmd+2+protein/recombinant+human+md+2++rhmd+2++or+rhmd+2+mutant++proteins/pm25923908-30-1-12
    Average 90 stars, based on 1 article reviews
    recombinant human md-2 (rhmd-2, or rhmd-2 mutant) proteins - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    human rhmd 2 fusion protein  (R&D Systems)
    94
    R&D Systems human rhmd 2 fusion protein
    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding <t>to</t> <t>MD2</t> promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway
    Human Rhmd 2 Fusion Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+md+2+rhmd+2+protein/Recombinant+Human+MD-2+Protein/pm26330549-77-6-10
    Average 94 stars, based on 1 article reviews
    human rhmd 2 fusion protein - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding to MD2 promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway

    Journal: Journal of cellular and molecular medicine

    Article Title: 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.

    doi: 10.1111/jcmm.13820

    Figure Lengend Snippet: FIGURE 6 Proposed model of 25HC preventing LPS‐induced TLR4 signalling pathway. LPS binding to MD2 promotes the dimerization of TLR4/MD‐2. The conformational changes in the TLR4 induce the recruitment of intracellular adaptor proteins to activate the downstream signalling pathway. The MyD88‐dependent pathway involves activation of MAPK cascades and IKK (IκB kinase). Phosphorylation of IKKs leads to degradation of IκBα and the release of NF‐κB. Transcription factors such as NF‐κB, AP‐1 and etc. participate in driving gene expression of proinflammatory cytokines. The activated PI3K/Akt in the downstream of TLR4 induces nuclear translation of NF‐κB. 25HC could directly interact with MD2 to prevent LPS‐induced activation of Akt and NF‐κB signal pathway

    Article Snippet: Recombinant human MD‐2 (rhMD‐2) protein was obtained from R&D Systems (Minneapolis, MN, USA).

    Techniques: Binding Assay, Activation Assay, Phospho-proteomics, Gene Expression